Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent

Molecular Pharmacology

Volumn 54, Issue 1, 1998, Pages 8-13

  Loeper, Jacqueline ^a,b   Louérat Oriou, Bénédicte ^a   Duport, Catherine ^a   Pompon, Denis ^a  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; DEXTROMETHORPHAN; HYDROPEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON TRANSPORT; ENZYME ACTIVITY; GENE DELETION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

EID: 2642611948     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.1.8     Document Type: Article

References (38)

1. Beaune PH, Dansette PM, Kiffel L, Finck M, Amar C, Leroux JP, and Homberg JC (1987) Human anti-endoplasmic reticulum autoantobodies appearing in a drug induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug. Proc Natl Acad Sci USA 84:551-555.
2. Beaune PH, Pessayre D, Dansette P, Mansuy D, and Manns M (1994) Autoantibodies against cytochrome P450: role in human diseases. Adv Pharmacol 30:199-245.
3. Bourdi M, Larrey D, Nataf J, Bernuau J, Pessayre D, Iwasaki M, Guengerich FP, and Beaune PH (1990) Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P450 1A2: a specific marker of dihydralazine-induced hepatitis. J Clin Invest 85:1967-1973.
4. de Kerchove d'Exaerde A, Supply P, Dufour JP, Bogaerts P, Thines D, Goffeau A, and Boutry M (1995) Functional complementation of a null mutation of the yeast Saccharomyces cerevisiae plasma membrane H(+)-ATPase by a plant H(+)-ATPase gene. J Biol Chem 270:23828-23837.
5. Duport C, Spagnoli R, Degryse E, and Pompon D (1998) Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast. Nat Biotechnol 16: 186-189.
6. Eliasson E and Kenna JG (1996) Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50:573-582.
7. Fonne-Pfister R, Bargetzi MJ, and Meyer UA (1987) MPTP, the neurotoxin inducing Parkinson's disease is a potent competitive inhibitor of human and rat cytochrome isozymes (P450buf, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem Biophys Res Commun 148:1144-1150.
8. Gautier JC, Lecoeur S, Cosme J, Perret A, Urban P, Beaune PH and Pompon D (1996) Contribution of human cytochrome P450 to benzo(a)pyrene and benzo(a)pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast. Pharmacogenetics 6:489-499.
9. Ghersi-Egea JF, Leninger-Muller B, Suleman G, Siest G and Minn A (1994) Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62: 1089-1096.
10. Gueguen M, Meunier-Rotival M, Bernard O and Alvarez F (1988) Anti-liver -kidney microsome antibody recognizes a cytochrome P-450 from IID subfamily. J Exp Med 168:801-806.
11. Guengerich FP, Bryan WR, Sari MA and Ross JT (1991) Expression of mammalian cytochrome P450 enzymes using yeast-based vectors. Methods Enzymol 206:130-145.
12. Jarasch ED, Kartenbeck J, Bruder J, Fink A, Morré DJ, and Franke WW (1979) B-type cytochromes in plasma membranes isolated from rat liver, in comparison with those of endomembranes. J Cell Biol 80:37-52.
13. Kiffel L, Loeper J, Homberg JC, and Leroux JP (1989) A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune hepatitis. Biochem Biophys Res Commun 159:283-288.
14. Klausner RD and Dancis A (1994) A genetic approach to elucidating eukaryotic iron metabolism. FEBS Lett 355:109-113.
15. Lecoeur S, Andre C, and Beaune PH (1996) Tienilic acid-induced autoimmune hepatitis: anti-liver and -kidney microsomal antibodies type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9. Mol Pharmacol 50:326-333.
16. Leeder JS, Riley RJ, Cook VA, and Spielberg P (1992) Human anti-cytochrome P450 antibodies in aromatic anticonvulsivants-induced hypersensitivity reactions. J Pharmacol Exp Ther 263:360-367.
17. Lesuisse E, Casteras-Simon M, and Labbe P (1996) Evidence for the Saccharomyces cerevisiae ferrireductase system being a multicomponent electron transport chain. J Biol Chem 271:13578-13583.
18. Lesuisse E, Casteras-Simon M, and Labbe P (1997) Cytochrome P50 reductase is responsible for the ferrireductase activity associated with isolated plasma membranes of Saccharomyces cerevisiae. FEMS Microbiol Lett 156:147-152.
19. Loeper J, Descatoire V, Amouyal G, Letteron P, Larrey D, and Pessayre D (1989) Presence of covalently bound metabolites on rat hepatocyte plasma membrane proteins after administration of isaxonine, a drug leading to immunoallergic hepatitis in man. Hepatology 9:675-678.
20. Loeper J, Descatoire V, Maurice M, Beaune P, Feldmann G, Larrey D, and Pessayre D (1990) Presence of functional Cytochrome P-450 on isolated rat hepatocyte plasma membrane. Hepatology 11:850-858.
21. Loeper J, Descatoire V, Maurice M, Beaune P, Belghiti J, Houssin D, Ballet F, Feldmann G, Guengerich FP, and Pessayre D (1993) Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104:203-216.
22. Loeper J, Le Berre A, Pompon D (1998) Topology inversion of P450 2D6 (CYP2D6) in the endoplasmic reticulum is not required for plasma membrane transport. Mol Pharmacol 53:408-414.
23. Manns MP, Johnson EF, Griffin KJ, Tan EM, and Sullivan KF (1989) The major target antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is P450 db1. J Clin Invest 83:1066-1072.
24. Manns MP, Griffin KJ, Sullivan KF, and Johnson EF (1991) LKM1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P450 monooxygenase. J Clin Invest 88:1370-1378.
25. Nordblom GD, White RE, and Coon MJ (1976) Studies on hydroperoxide-dependent substrate hydroxylation by purified liver microsomal cytochrome P-450. Arch Biochem Biophys 175:524-533.
26. Parez N, Herzog D, Jacqz-Aigrain E, Homberg JC, and Alvarez F (1996) Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients. Clin Exp Immunol 106:336-343.
27. Pompon D, Louerat B, Bronine A, and Urban P (1996) Yeast expression of animals and plant P450s in optimized redox environments. Methods Enzymol 272:51-64.
28. Robin MA, Maratrat M, Le Roy M, Le Breton FP, Bonierbale E, Dansette P, Ballet F, Mansuy D, and Pessayre D (1996) Antigenic targets in tienilic acid hepatitis. J Clin Invest 98:1471-1480.
29. Robin MA, Maratrat M, Loeper J, Durand-Schneider AM, Tinel M, Ballet F, Beaune P, Feldmann G, and Pessayre D (1995) Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology 108:1110-1123.
30. Schmidt R, Ackermann R, Kratky Z, Wasserman B, and Jacobson B (1983) Fast and efficient purification of yeast plasma membranes using cationic silica microbeads. Biochim Biophy Acta 732:421-427.
31. Stasiecki P and Oesch F (1980) Distribution of enzymes involved in metabolism of polycyclic aromatic hydrocarbons among rat liver endomembranes and plasma membranes. Eur J Cell Biol 21:79-92.
32. Suzuki T, Fujita S, Narimatsu S, Masubuchi Y, Tachibana M, Ohta S, and Hirobe M (1992) Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes. FASEB J 6:771-776.
33. Tyndale R, Sunahara FR, Inaba T, Kalow W, Gonzalez FJ, and Niznik HB (1991) Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. Mol Pharmacol 40:63-68.
34. Wei MX, Tamiya T, Chase M, Boviatsis EJ, Chang TK, Kowall NK, Hochberg FH, Waxman DJ, Breakefield XO, and Chiocca EA (1994) Hum Gene Ther 5:969-978.
35. Wu D and Cederbaum AI (1992) Presence of functionally active cytochrome P-450 IIE1 in the plasma membrane of rat hepatocytes. Hepatology 15:515-524.
36. Yamamoto AM, Cresteil D, Boniface O, Clerc F, and Alvarez F (1993) Characterization of anti-liver-kidney microsome antibody (anti-LKM1) Eur J Immunol 23:1105-1111.
37. Zanger UM, Hauri HP, Loeper J, Homberg JC, and Meyer UA (1988) Antibodies against human cytochrome P-450 db1 in autoimmune hepatitis type II. Proc Natl Acad Sci USA 85:8256-8260.
38. Zinser E, Sperka-Gottlieb CD, Fasch EV, Kohlwein SD, Paltauf F, and Daum G (1991) Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote Saccharomyces cerevisiae. J Bacteriol 173:2026-2034.